Showing all 5 results
Afatinib Tablets
FreeProduct Composition & Strength
We supply this product in multiple strengths to allow for precise dose titration based on patient tolerability.
Active Ingredient Strength Primary Clinical Function Afatinib (as Dimaleate) USP/Ph.Eur. 20 mg / 30 mg The Dose-Adjustment Unit: Used for patients requiring a lower dose due to gastrointestinal or skin toxicity. Afatinib (as Dimaleate) USP/Ph.Eur. 40 mg The Standard Therapeutic Anchor: The globally validated starting dose for first-line treatment of EGFR+ NSCLC. Excipients Proprietary Matrix Bio-Stable Coating: Engineered to protect the sensitive dimaleate salt and ensure consistent systemic absorption. Anastrozole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Cytotoxic Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Anastrozole USP/Ph.Eur. 1 mg The Standard Oncology Anchor: The globally validated dose for both adjuvant and first-line treatment of advanced breast cancer. Excipients Proprietary Matrix High-Containment Coating: Engineered with an impenetrable film-coat to prevent the release of cytotoxic dust, ensuring safety for healthcare workers. Bicalutamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Cytotoxic Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Bicalutamide USP/Ph.Eur. 50 mg The Metastatic Anchor: Used in combination with a LHRH analogue (medical castration) for advanced metastatic disease. Bicalutamide USP/Ph.Eur. 150 mg The Monotherapy Payload: Utilized as a standalone treatment for locally advanced, non-metastatic prostate cancer. Excipients Proprietary Matrix High-Containment Coating: Engineered with an impenetrable film-coat to prevent the release of cytotoxic dust during handling by healthcare professionals. Cyclophosphamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Cytotoxic Prodrug Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the sensitive nitrogen mustard derivative and to physically protect caregivers from API exposure.
Active Ingredient Strength Primary Clinical Function Cyclophosphamide USP/Ph.Eur.
(as Cyclophosphamide Monohydrate)50 mg The Oncology & Autoimmune Macrodose: The definitive oral therapeutic unit utilized for chronic, daily continuous “metronomic” chemotherapy regimens and severe immunosuppressive maintenance. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Starch / Magnesium Stearate / Heavy Sucrose or Polymeric Film-Coat Diluent / Densifier / Disintegrant / Lubricant / Protective Cytotoxic Shield (Engineered specifically utilizing a thick, impenetrable sugar or film coat to ensure the highly toxic API never comes into contact with the skin of the patient, pharmacist, or caregiver handling the pill) *Pack Sizes: Bottles of 50/100 or 10×10 Alu-Alu Blisters (Optimized specifically for strict chronic oncology and rheumatology dispensing regimens).
Thioguanine Tablets
FreeProduct Composition & Strength
We supply this product in the globally standardized 40 mg strength, optimized for adult and pediatric weight-based dosing.
Active Ingredient Strength Primary Clinical Function Thioguanine USP/Ph.Eur. 40 mg The DNA Saboteur: Mimics guanine to stop the replication of leukemic cells. Excipients Pharmaceutical Grade Stability Matrix: Engineered to protect the sensitive API from environmental degradation.
